- Home
- AGMH vs BRNS Comparison
AGMH vs BRNS Comparison
Compare AGMH & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- BRNS
- Stock Information
- Founded
- AGMH 2015
- BRNS 2016
- Country
- AGMH Hong Kong
- BRNS United Kingdom
- Employees
- AGMH N/A
- BRNS N/A
- Industry
- AGMH EDP Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- AGMH Technology
- BRNS Health Care
- Exchange
- AGMH Nasdaq
- BRNS Nasdaq
- Market Cap
- AGMH 1.8M
- BRNS 28.2M
- IPO Year
- AGMH 2018
- BRNS 2021
- Fundamental
- Price
- AGMH $0.05
- BRNS $0.82
- Analyst Decision
- AGMH
- BRNS Strong Buy
- Analyst Count
- AGMH 0
- BRNS 2
- Target Price
- AGMH N/A
- BRNS $3.00
- AVG Volume (30 Days)
- AGMH 73.2M
- BRNS 25.9K
- Earning Date
- AGMH 06-18-2025
- BRNS 05-12-2025
- Dividend Yield
- AGMH N/A
- BRNS N/A
- EPS Growth
- AGMH N/A
- BRNS N/A
- EPS
- AGMH N/A
- BRNS N/A
- Revenue
- AGMH $64,998,081.00
- BRNS $14,969,000.00
- Revenue This Year
- AGMH N/A
- BRNS N/A
- Revenue Next Year
- AGMH N/A
- BRNS N/A
- P/E Ratio
- AGMH N/A
- BRNS N/A
- Revenue Growth
- AGMH N/A
- BRNS 1766.46
- 52 Week Low
- AGMH $0.02
- BRNS $0.64
- 52 Week High
- AGMH $2.19
- BRNS $2.60
- Technical
- Relative Strength Index (RSI)
- AGMH 36.92
- BRNS 51.00
- Support Level
- AGMH $0.04
- BRNS $0.68
- Resistance Level
- AGMH $0.08
- BRNS $0.97
- Average True Range (ATR)
- AGMH 0.01
- BRNS 0.08
- MACD
- AGMH 0.02
- BRNS 0.02
- Stochastic Oscillator
- AGMH 48.36
- BRNS 54.79
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.